The P.K. Shah Laboratory research is focused on identifying novel molecular mechanisms and pathways leading to inflammation and atherosclerosis and developing novel therapies to prevent, stabilize and reverse atherosclerosis. Current investigations include:
- Identifying novel molecular mechanisms and pathways in the pathophysiology of atherosclerotic cardiovascular disease
- Developing novel gene-based therapies for prevention, stabilization and reversal of atherosclerosis
- Defining the role of autoimmunity in atherosclerosis and developing a vaccine for atherosclerosis, aortic aneurysm and hypertension
The P.K. Shah Laboratory is affiliated with the Smidt Heart Institute, Department of Medicine and Oppenheimer Atherosclerosis Research Center.